[Back]
Ass.-Prof. Dipl.-Ing. Karin Ortmayr, PhD
Karin Ortmayr
T: +43-1-4277-55273
https://pharmakognosie.univie.ac.at/people/ortmayr-karin/
1 - 20 out of 25
Pfleger T, Ortmayr K, Steiner K, Zaher R, Seiser S, Elbe-Bürger A et al. Radical scavenging effect of skin delivery systems using Korean red ginseng extract and assessment of their biocompatibility with human primary dermal fibroblasts and HaCaT keratinocytes. International Journal of Pharmaceutics. 2025 Apr 15;674:125477. doi: 10.1016/j.ijpharm.2025.125477
Schuhknecht L, Ortmayr K, Jänes J, Bläsi M, Panoussis E, Bors S et al. A human metabolic map of pharmacological perturbations reveals drug modes of action. Nature Biotechnology. 2025 Jan 28. doi: 10.1038/s41587-024-02524-5
Eichenauer E, Sykora C, Ortmayr K, Glasl S. “Radix Saniculae”: Phytochemical Characterization and Potential Adulteration of an Austrian Traditional Wound-Healing Agent. Plants. 2025 Jan 18;14(2):266. doi: 10.3390/plants14020266
Schwarzinger J, Adelsberger S, Ortmayr K, Stellnberger SL, Tahir A, Hädrich G et al. Biopharmaceutical profiling of anti-infective sanggenons from Morus alba root bark for inhalation administration. International journal of pharmaceutics: X. 2024 Dec;8:100272. Epub 2024 Aug 5. doi: 10.1016/j.ijpx.2024.100272
Ortmayr K, Zampieri M. Sorting‐free metabolic profiling uncovers the vulnerability of fatty acid β‐oxidation in in vitro quiescence models. Molecular Systems Biology. 2022 Sept;18(9):e10716. doi: 10.15252/msb.202110716
Ortmayr K, Moreno RDLC, Zampieri M. Expanding the search for small-molecule antibacterials by multidimensional profiling. Nature Chemical Biology. 2022 Jun;18(6):584-595. doi: 10.1038/s41589-022-01040-4
Anglada-Girotto M, Handschin G, Ortmayr K, Campos AI, Gillet L, Manfredi P et al. Combining CRISPRi and metabolomics for functional annotation of compound libraries. Nature Chemical Biology. 2022 May;18(5):482-491. doi: 10.1038/s41589-022-00970-3
Ortmayr K, Dubuis S, Zampieri M. Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism. Nature Communications. 2019 Apr 23;10(1):1841. doi: 10.1038/s41467-019-09695-9
Ortmayr K, Dubuis S, Zampieri M. A framework for large-scale metabolome drug profiling links coenzyme A metabolism to the toxicity of anti-cancer drug dichloroacetate. Communications Biology. 2018 Aug 3;1(1):101. doi: 10.1038/s42003-018-0111-x
Ortmayr K, Charwat V, Kasper C, Hann S, Koellensperger G. Uncertainty budgeting in fold change determination and implications for non-targeted metabolomics studies in model systems. The Analyst. 2017 Jan 1;142(1):80-90. doi: 10.1039/c6an01342b
Ortmayr K, Causon TJ, Hann S, Koellensperger G. Increasing selectivity and coverage in LC-MS based metabolome analysis. Trends in Analytical Chemistry. 2016 Sept;82:358-366. doi: 10.1016/j.trac.2016.06.011
Ortmayr K, Schwaiger M, Drexler H, Mairinger T, Causon T, Hann S et al. Metabolomics trifft Methodenvalidierung - Analytische Herausforderungen in der modernen ungezielten Metabolomanalyse mittels LC-MS. In Book of Abstracts. 2016
Megson ZA, Pittenauer E, Duda KA, Engel R, Ortmayr K, Koellensperger G et al. Inositol-phosphodihydroceramides in the periodontal pathogen Tannerella forsythia: Structural analysis and incorporation of exogenous myo-inositol. Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 2015 Nov;1851(11):1417-1427. doi: 10.1016/j.bbalip.2015.08.004
Hermann G, Rampler E, Ortmayr K, Schwaiger M, Neubauer S, Chu DB et al. The assisting role of elemental speciation analysis in metabolomics and proteomics. In Book of Abstracts. 2015
Ortmayr K, Schwaiger M, Drexler H, Mairinger T, Hermann G, Causon T et al. Towards validating LC-MS based metabolomics – overcoming analytical challenges with chromatographic enhancements and normalization strategies. In Book of Abstracts. 2015
Ortmayr K, Hann S, Köllensperger G. Towards validating LC-MS based metabolomics – chromatographic enhancements and normalization strategies. In Rainer M, editor, Book of Abstracts. 2015
Mairinger T, Drexler H, Chu DB, Neubauer S, Troyer C, Ortmayr K et al. Measurement uncertainty of isotopologue fractions determined via mass spectrometry for metabolic flux analysis. In Samuel L, editor, Book of Abstracts. 2015
Ortmayr K, Hann S, Köllensperger G. Complementing reversed phase selectivity with porous graphitized carbon to increase the metabolome coverage in an on-line two-dimensional LC-MS setup for metabolomics. In Gössler W, Leitner E, Wiltsche H, editors, Book of Abstracts. 2015
Hermann G, Neubauer S, Chu DB, Ortmayr K, Hann S, Köllensperger G. Elemental speciation analysis - current developments and future perspectives. In Gössler W, Leitner E, Wiltsche H, editors, Book of Abstracts. 2015
Mairinger T, Drexler H, Chu DB, Neubauer S, Troyer C, Ortmayr K et al.. Neue massenspektrometrische Analysenstrategien für Fluxomics und Metabolomics in der industriellen Biotechnologie. 2015. Paper presented at 32. Forum Analytik Wien, Wien, Austria.
1 - 20 out of 25

Sanggenons for inhalation? Biopharmaceutical profiling of anti-infectives from Morus alba root bark

Adelsberger, S. (Speaker), Schwarzinger, J. (Contributor), Ortmayr, K. (Contributor), Stellnberger, S. (Contributor), Tahir, A. (Contributor), Hädrich, G. (Contributor), Pichler, V. (Contributor), Rollinger, J. M. (Contributor), Dailey, L. A. (Contributor) & Grienke, U. (Contributor)

4 Jul 2024

Activity: Talks and presentations › Talk or oral contribution › Science to Science

Metabolomics trifft Methodenvalidierung - Analytische Herausforderungen in der modernen ungezielten Metabolomanalyse mittels LC-MS.

Ortmayr, K. (Invited speaker)

9 Feb 2016

Activity: Talks and presentations › Talk or oral contribution › Other

Towards validating LC-MS based metabolomics – overcoming analytical challenges with chromatographic enhancements and normalization strategies

Ortmayr, K. (Speaker)

6 Sept 2015

Activity: Talks and presentations › Talk or oral contribution › Other

Towards validating LC-MS based metabolomics – chromatographic enhancements and normalization strategies

Ortmayr, K. (Speaker)

12 Jun 2015

Activity: Talks and presentations › Talk or oral contribution › Other

Complementing reversed phase selectivity with porous graphitized carbon to increase the metabolome coverage in an on-line two-dimensional LC-MS setup for metabolomics

Ortmayr, K. (Speaker)

23 Mar 2015

Activity: Talks and presentations › Talk or oral contribution › Other

Anti-Infectives Drug Discovery

Rollinger, J. M. (Project Lead), Dailey, L. A. (Co-Lead), Orts, J. (Co-Lead), Böttcher, T. (Co-Lead), Schmidt, M. (Co-Lead), Rademacher, C. J. H. (Co-Lead), Schützenmeister, N. (Co-Lead), Zotchev, S. (Co-Lead), Kirchmair, J. (Co-Lead) & Ortmayr, K. (Co-Lead)

1/07/25 → 30/06/29

Project: Research funding

Parsing metabolic regulatory mechanisms in cancer recurrence

Ortmayr, K. (Project Lead)

1/07/24 → 30/06/27

Project: Research funding

Department of Pharmaceutical Sciences

Josef-Holaubek-Platz 2 (UZA II)
1090 Wien
Room: 2F403

T: +43-1-4277-55273

karin.ortmayr@univie.ac.at